Hut 8 Prices $4.25 Billion in Notes to Fund Texas Data Center
Hut 8 has priced $4.25 billion in notes to fund a Texas data center, marking a major financing move tied to its infrastructure growth plans.
Breaking crypto news, market-moving developments, regulation updates, and major announcements tracked by AiCryptoCore.
Hut 8 has priced $4.25 billion in notes to fund a Texas data center, marking a major financing move tied to its infrastructure growth plans.
Spot Ethereum ETFs posted $19.3 million in net inflows on June 4. This outline focuses on the daily flow data, key drivers, and what it signals for ETH sentiment.
ChosunBiz says South Korean police are probing Polymarket users over suspected illegal gambling, putting prediction market compliance in focus.
This Wu Blockchain podcast episode features GMTrade co-founder William discussing GMTrade’s evolution from its GMX Solana roots and the project’s broader market...
Bankless co-founder Ryan Sean Adams argues Ethereum only succeeds if ETH becomes a global store of value. Here is the core thesis and why it matters.
Galaxy Research says spot Bitcoin ETFs recorded a record 13 straight days of net outflows.
CryptoQuant says Bitcoin short-term holders are showing the year’s strongest capitulation signal. Here’s what the data may mean for price sentiment.
FG Nexus’ Ethereum treasury strategy losses have topped $85 million, raising fresh questions about balance-sheet risk, crypto exposure, and investor confidence.
Bitmine plans 3 million shares of 9.50% perpetual preferred stock. This outline focuses on the filing details, funding angle, and next steps to watch.
Analyze Binance’s disclosed minority stake in Alpaca, the company tied to roughly 94% custody market share, and what that could mean for crypto markets.
The UK FCA has warned football clubs about legal and anti-money-laundering risks tied to unauthorized crypto sponsors, raising compliance concerns for future deals.
Brian Armstrong-backed longevity startup NewLimit has raised $435 million in Series C funding, signaling major investor confidence in biotech innovation.